| 000 | 03161nam a22003975i 4500 | ||
|---|---|---|---|
| 001 | 86768 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040614.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 160111s2016 si | s |||| 0|eng d | ||
| 020 | _a9789811000638 | ||
| 040 | _aES-MaUEC | ||
| 050 | 4 |
_aR857.N34 _bA383 2016 EB |
|
| 082 | 0 | 4 | _a610.28 |
| 245 | 1 | 0 |
_aAdvances in Nanotheranostics II : _bCancer Theranostic Nanomedicine _cedited by Zhifei Dai |
| 260 |
_aSingapore _bSpringer _c2016 |
||
| 300 | _a1 recurso en línea (XI, 381 p.) 158 il., 141 il. col. | ||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 490 | 1 |
_aSpringer Series in Biomaterials Science and Engineering _x2195-0644 _v7 |
|
| 520 | _aThis book surveys recent advances in theranostics based on magnetic nanoparticles, ultrasound contrast agents, silica nanoparticles and polymeric micelles. It presents magnetic nanoparticles, which offer a robust tool for contrast enhanced MRI imaging, magnetic targeting, controlled drug delivery, molecular imaging guided gene therapy, magnetic hyperthermia, and controlling cell fate. Multifunctional ultrasound contrast agents have great potential in ultrasound molecular imaging, multimodal imaging, drug/gene delivery, and integrated diagnostics and therapeutics. Due to their diversity and multifunctionality, polymeric micelles and silica-based nanocomposites are highly capable of enhancing the efficacy of multimodal imaging and synergistic cancer therapy. This comprehensive book summarizes the main advances in multifunctional nanoprobes for targeted imaging and therapy of gastric cancer, and explores the clinical translational prospects and challenges. Although more research is needed to overcome the substantial obstacles that impede the development and availability of nanotheranostic products, such nontrivial nanoagents are expected to revolutionize medical treatments and help to realize the potential of personalized medicine to diagnose, treat, and follow-up patients with cancer. Zhifei Dai is a Professor at the Department of Biomedical Engineering, College of Engineering, Peking University, China. | ||
| 942 |
_2lcc _cLE |
||
| 988 | 0 | 0 | _aEBOOK, EBSPRINGER |
| 650 | 7 |
_aRadiología _0comprobar BNE19900979139 _2embne _9139971 |
|
| 650 | 7 |
_aOncología _0comprobar BNE19900969554 _2embne _9139207 |
|
| 650 | 0 | 7 |
_aIngeniería _vCongresos y asambleas _0LocalX _2embne _9670301 |
| 700 | 1 |
_aDai, Zhifei _eeditor literario _0Local _9100226 |
|
| 830 | 0 |
_aSpringer Series in Biomaterials Science and Engineering _x2195-0644 _v7 _9134327 _0Local |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-981-10-0063-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 901 | _ai9789811000638 | ||
| 907 |
_a.b12960469 _b10-10-17 _c21-11-16 |
||
| 998 |
_am _a_alco _a_vill _b - - _cm _dz _e- _feng _gsi _h0 |
||
| 945 |
_aR857.N34 A383 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11601486 _z06-04-17 |
||
| 999 |
_c86768 _d86768 _x1 |
||